PHASE 2 STUDY OF IBRUTINIB IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA: UPDATED SAFETY ANALYSIS ON PREVALENCE OF INFECTION, DIARRHEA, AND BLEEDING OVER TIME Rule, S., Wang, M. L., Martin, P., Auer, R., Kahl, B. S., Jurczak, W., Advani, R. H., Romaguera, J., Williams, M., Barrientos, J. C., Chmielowska, E., Radford, J. A., Stilgenbauer, S., Truong, V., Chang, M., Beaupre, D. M., Goy, A., Blum, K. A. FERRATA STORTI FOUNDATION. 2014: 150

View details for Web of Science ID 000342830900361